Rocket Lab Drops 6% as Citizens Cuts Target Over Neutron Delay; Planet Labs Slides 5%, SpaceX Slips
Rocket Lab's Neutron rocket just slipped past a key deadline, and Wall Street is starting to reprice how long investors will wait for the launch revenue that underpins the entire bull case.
A delayed debut for Rocket Lab‘s (NASDAQ:RKLB | RKLB Price Prediction) next-generation rocket is weighing on space stocks. Rocket Lab stock is down 6% to $51.97 in afternoon trading, extending a slide that began after the company pushed back the first launch of its Neutron rocket.
Meanwhile, Planet Labs (NYSE:PL) stock is down 5% to $13.74, following Rocket Lab lower. SpaceX (NASDAQ:SPCX) stock is down 2% to $146.26, a softer decline than its two space peers.
One diverse space fund is holding up far better. The Procure Space ETF (NASDAQ:UFO) is down 0.9%, a gap that marks the selloff as specific to Rocket Lab stock. For comparison, over in large caps, the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is down 0.75%.
Neutron Delay Draws a Citizens Target Cut
On Wednesday, Rocket Lab stated that Neutron’s first launch has slipped from the fourth quarter of this year into next year. Rocket Lab shares fell sharply on the news. Citizens then cut its price target on Rocket Lab stock while keeping its Outperform rating.
In its note, Citizens stated that the delay’s biggest impact falls on how quickly Rocket Lab can earn revenue from later Neutron launches. Keeping the Outperform rating signals that the firm still sees upside for Rocket Lab shares even with a lower target.
The new timeline marks a shift from August, when Rocket Lab founder Peter Beck stated on the company’s Q2 2026 earnings call that “Production currently lines up with our target delivery of Neutron to the pad in Q4 2026.” Beck also maintained, “Our focus is on the bigger picture and making sure that when Neutron flies, it enters service as a system ready for full scale production and high cadence launch.”
Launch Demand Meets a Longer Wait
Rocket Lab flies its Electron small-lift rocket and builds spacecraft and components while developing Neutron, a reusable medium-lift rocket built for larger commercial satellite, civil space and national security missions. SpaceX runs its own launch business and Starlink satellite network. Planet Labs operates Earth-imaging satellites and sells the data to government, defense and commercial customers.
In Q2, Rocket Lab posted revenue of $234.1 million, up 62% year over year, while its backlog rose to a record $2.36 billion. Its acquisitions of laser communications firm Mynaric and space robotics firm Motiv had also closed by the time of that report.
For Rocket Lab, the optimistic outlook rests on demand for medium-lift launches once Neutron flies. Beck stated on the call, “The market is saying, from the customer perspective, is not saying if, it’s more when.” Dedicated Neutron launch contracts already on Rocket Lab’s books include one for a U.S. Space Force program and another for Kepler Communications, which reserved an entire rocket for the first time.
For Rocket Lab, the main concern is the longer wait before Neutron produces launch revenue. Adam Spice, speaking as chief financial officer on the August call, stated that the timing of positive free cash flow remains tied to Neutron’s first successful test launch. Management added that reaching cash-flow positivity on a standalone basis could take 18 to 24 months after that shift, so a later first flight may push that window further out.
Rocket Lab made up 3.6% of the Procure Space ETF’s net assets as of July 31, with Planet Labs at 3.7% and SpaceX at 3.8%. The UFO fund’s remaining holdings span satellite communications, Earth observation, navigation and aerospace names, a mix that helps explain its much smaller decline.
Neutron Timing Sets the Next Move
A key test comes with Rocket Lab’s next quarterly report, which will show whether its Q3 2026 revenue outlook of $250 million to $265 million holds. Management expects early Neutron demand to stay firm, having stated on the August call, “We’ve had absolutely zero issues in selling, you know, full price neutrons pre-test flights.”
Until Neutron flies, execution risk for Rocket Lab stays elevated. Investors who like the long-term launch story can stay lightly invested in Rocket Lab stock and leave room to add once the timeline resolves.
Contact [email protected] for any questions or corrections.
David Moadel is financial writer specializing in stocks, ETFs, options, precious metals, and Bitcoin. David has written well over 1,000 articles for leading online publications, helping investors understand markets, income strategies, and risk.His work has appeared in The Motley Fool, InvestorPlace, U.S. News & World Report, TipRanks, ValueWalk, Benzinga, Market Realist, TalkMarkets, Finmasters, 24/7 Wall St., and others.With a master’s degree in education, David has taught at the elementary, high school, and college levels. That teaching background shapes his writing style: clear, educational, and practical. David has also built a loyal social-media audience by providing trustworthy financial content on YouTube, X/Twitter, and StockTwits.
